Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nonmyeloablative Haploidentical PBSC Transplant for Hematologic Malignancies
NCT01028716Phase 2Terminated
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- May 2010
- Primary completion
- Oct 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of peripheral blood stem cells in hematologic malignancy, sponsored by Fred Hutchinson Cancer Center. Started May 2010; status: terminated.
02
Drugs
peripheral blood stem cells
03
Conditions
hematologic malignancy
Beyond the preview
Go deeper on NCT01028716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01028716.